Relapsing fever

Introduction

Relapsing fever is an infectious disease characterized by recurring episodes of high fever, chills, headache, muscle and joint aches. It’s caused by certain bacteria of the genus Borrelia and transmitted usually by lice or ticks. While relatively uncommon in modern urban settings, in some rural or refugee-populated areas it still causes notable health burdens. People with relapsing fever often endure cycles of illness and recovery, deeply affecting daily activities, work attendance, and overall quality of life. In this article, we’ll preview symptoms of relapsing fever, causes and risk factors, medical evaluation, treatment options and outlook so stick around if you want a clear, evidence-based overview.

Definition and Classification

Medically, relapsing fever refers to a set of bacterial infections marked by repeated febrile episodes separated by symptom-free intervals. It’s classified mainly into two groups:

• Louse-borne relapsing fever (transmitted by human body lice; often epidemic in crowded, low-hygiene settings)
• Tick-borne relapsing fever (fever cycles caused by various soft tick species like Ornithodoros)

Relapsing fever can be acute with rapid onset or follow a more protracted, relapsing-remitting course. While not considered malignant such as cancer, it is systemic and can involve multiple organs especially the blood, central nervous system, liver, spleen, and occasionally heart valves. Subtypes vary by geography (e.g., East African relapsing fever vs. North American tick-borne relapsing fever) and subtle differences in clinical presentation.

Causes and Risk Factors

The root cause of relapsing fever is infection by spirochetal bacteria of the Borrelia genus. These spiral-shaped organisms invade the bloodstream, triggering high fevers. Main transmission routes include:

• Lices carrying Borrelia recurrentis in close, overcrowded human habitats
• Soft ticks (e.g., Ornithodoros hermsi, O. turicata) that harbor species like Borrelia hermsii

Key risk factors:

• Non-modifiable: living in endemic regions (East Africa, parts of Asia, mountainous areas of western U.S.), previous exposure, age extremes (newborns and elderly more vulnerable).
• Modifiable: poor hygiene, sleeping in rustic on-ground cabins or rodent-infested shelters, inadequate vector control.

Environmental elements like rodent reservoirs (mice, squirrels) and seasonal tick activity shape exposure risk. Outbreaks of louse-borne relapsing fever often coincide with war, displacement, and refugee camps where hygiene suffers. On the other hand, hikers and backpackers occasionally contract tick-borne relapsing fever after sleeping in rodent-rich cabins. Sometimes, the precise cause of a particular patient’s relapse pattern isn’t fully understood—immune evasion by Borrelia via antigenic variation complicates the picture.

Pathophysiology (Mechanisms of Disease)

Once Borrelia enters the bloodstream, it bypasses initial skin defenses and multiplies. The hallmark of relapsing fever is antigenic variation: the bacteria switch their surface proteins (variable major proteins, VMPs) every several days, helping them dodge the host’s emerging antibodies. This cyclical immune escape explains why patients have fever spikes (when new VMPs emerge unchecked) and remission periods (when antibodies clear the previous variant).

At a cellular level, inflammatory mediators like cytokines (TNF-alpha, IL-6) are released in response to spirochetes, causing fever, chills, and malaise. Microvascular changes and increased vascular permeability contribute to headache and muscle aches. In severe cases, Borrelia can invade the central nervous system, causing meningitis-like symptoms, or trigger a Jarisch–Herxheimer reaction after antibiotic therapy—an acute inflammatory response that demands careful clinical management.

Symptoms and Clinical Presentation

Clinical features of relapsing fever generally unfold in distinct phases:

• Incubation (2–15 days post-bite or louse exposure): often asymptomatic or mild prodrome with fatigue, low-grade fever.
• Febrile crisis (3–7 days): abrupt high fever (≥39°C/102°F), severe chills, rigors, intense headache, photophobia, arthralgias, and myalgias. Nausea, vomiting, sometimes abdominal pain and diarrhea.
• Defervescence (1–3 days): fever breaks, drenching sweats, temporary relief.
• Relapse (3–14 days): fever returns, often less intense; can repeat several times unless treated.

Variability abounds: some people display mild, almost flu-like symptoms that resolve spontaneously, while others experience severe systemic signs. Warning signs requiring urgent care:

• Rapidly dropping blood pressure, confusion or altered consciousness (possible meningitis or sepsis).
• Severe anemia or bleeding tendencies from hemolysis.
• Signs of cardiac involvement: chest pain, arrhythmias.
• Intense Jarisch–Herxheimer reaction after antibiotics: worsening fever, hypotension within hours of treatment.

Note: this is not a self-diagnosis guide, but if you have recurrent fevers after travel or tick/louse exposure, seek medical evaluation promptly.

Diagnosis and Medical Evaluation

Diagnosing relapsing fever usually begins with a thorough history (travel, living conditions, tick or lice exposure) and physical exam. Lab tests include:

• Peripheral blood smear during febrile episodes: direct visualization of spirochetes under dark-field or Giemsa stain.
• Serologic assays: ELISA or Western blot to detect antibodies against Borrelia, though early testing may be falsely negative.
• Polymerase chain reaction (PCR): high sensitivity for Borrelia DNA in blood, particularly useful in tick-borne relapsing fever.
• Complete blood count: often shows leukocytosis, anemia, thrombocytopenia.
• Liver function tests: mild transaminase elevations common.

Imaging (CT or MRI) is rarely needed but may be employed if neurological involvement is suspected. Differential diagnosis includes malaria, typhoid fever, Dengue, malaria—anything that causes cyclical fevers in returning travelers. A typical pathway: suspect relapsing fever → collect blood sample at fever peak → microscopic smear + PCR → start empiric antibiotics if strong suspicion exists (don’t wait for culture growth!).

Which Doctor Should You See for Relapsing fever?

Wondering “which doctor to see for relapsing fever”? You’ll likely start with a primary care physician or an infectious disease specialist. Emergency care may be necessary if you’re hypotensive, confused, or showing signs of severe anemia. In rural areas, local health clinics with telemedicine links to tropical medicine experts can guide initial work-up.

Online consultations are great for second opinions, interpreting lab results, or clarifying diagnosis—especially if you’re in a remote region. But remember: telemedicine can’t replace essential physical exams, blood draws, or urgent IV treatments. Use virtual care to complement your in-person visits and ensure you get treated promptly.

Treatment Options and Management

First-line therapy for relapsing fever is typically antibiotics such as:

• Doxycycline (100 mg orally twice daily for 7–10 days) – preferred in adults; note it’s contraindicated in pregnant women.
• Penicillin G or Ceftriaxone for pregnant patients and those unable to take doxycycline.

During antibiotic initiation, monitor closely for Jarisch–Herxheimer reaction: a transient worsening of symptoms due to rapid spirochete death. Supportive care includes IV fluids, antipyretics (acetaminophen), and oxygen if needed. In severe cases with complications (meningitis, myocarditis), hospitalization and prolonged therapy may be required. Rehab for lingering fatigue or anemia involves iron supplementation and gradual activity resumption.

Prognosis and Possible Complications

With prompt, appropriate treatment, the prognosis of relapsing fever is generally good—most patients recover fully. Untreated or delayed therapy may lead to:

• Severe anemia from hemolysis
• CNS involvement: meningitis, neuropathies
• Cardiac issues: endocarditis, myocarditis
• Death in up to 5–10% of louse-borne cases without treatment (rare in tick-borne forms)

Factors influencing outlook include age (higher risk in newborns and the elderly), comorbidities (HIV, malnutrition), and access to healthcare. Early recognition, rapid antibiotic therapy, and management of Jarisch–Herxheimer reactions are critical to reduce morbidity and mortality.

Prevention and Risk Reduction

Preventing relapsing fever revolves around vector avoidance and hygiene:

• For tick-borne relapsing fever: use insect repellents (DEET), wear long sleeves and pants, inspect skin daily after outdoor activities, seal cracks in cabins to deter rodents.
• For louse-borne relapsing fever: maintain personal and community hygiene—regular washing of clothes and bedding in hot water, avoiding overcrowded shelters without lice control.

Rodent control around homes and campsites reduces soft tick exposure—store food properly, close off rodent burrows. No vaccine currently exists, so behavioral measures are your main defense. Health education in endemic areas is essential: teaching locals to recognize early symptoms and seek care. Screening programs aren’t routine, but outbreak investigations often include active case finding through local clinics.

Myths and Realities

Relapsing fever attracts myths, partly due to its dramatic fever cycles and old-world associations:

• Myth: “It’s only a problem in Africa.” Reality: Tick-borne relapsing fever exists in parts of the U.S., Europe, Asia—anywhere soft ticks or lice circulate.
• Myth: “One dose of antibiotic cures everything.” Reality: You need a full course of appropriate antibiotics and monitoring for Jarisch–Herxheimer reactions.
• Myth: “Only filthy people get it.” Reality: Even hikers in clean gear can pick up infected ticks in mountain cabins.
• Myth: “Natural remedies will clear the bacteria.” Reality: No herbal tea or essential oil has proven to eradicate Borrelia recurrentis or tick-borne species—antibiotics remain the only evidence-based cure.

By debunking these misconceptions, patients and communities can focus on proven prevention and early treatment, reducing stigma and improving outcomes.

Conclusion

Relapsing fever, though less common in developed urban centers, remains a significant infectious threat in specific settings. It presents with recurring high fevers, chills, headaches, and systemic symptoms—driven by Borrelia species transmitted via lice or soft ticks. Accurate diagnosis hinges on blood smears, PCR, and clinical history, while treatment relies on antibiotics plus vigilant management of Jarisch–Herxheimer reactions. Prognosis is favorable when therapy begins early, but delayed care can lead to anemia, neurological or cardiac complications. Prevention focuses on vector control, personal hygiene, and public health education.

If you suspect relapsing fever due to travel, tick bites, or living conditions consult a qualified healthcare professional without delay. Early evaluation and treatment are the best ways to break the cycle of relapse and recovery. 

Frequently Asked Questions (FAQ)

• Q: What causes relapsing fever?
  A: It’s caused by Borrelia bacteria transmitted by lice or soft ticks, which enter the bloodstream and trigger fever cycles.
• Q: How soon do symptoms appear?
  A: Incubation typically ranges from 2 to 15 days after exposure to the infected vector.
• Q: Why does fever keep coming back?
  A: Borrelia changes its surface proteins (antigenic variation), evading the immune system and causing relapse.
• Q: Can I diagnose it at home?
  A: No. Diagnosis requires blood tests—microscopy, PCR, or serology performed by a lab.
• Q: Which doctor treats relapsing fever?
  A: Primarily infectious disease specialists or primary care physicians; emergency doctors if severe symptoms arise.
• Q: What’s the main treatment?
  A: Doxycycline is first-line; pregnant patients often get penicillin or ceftriaxone instead.
• Q: Is there a vaccine?
  A: Currently no vaccine exists for relapsing fever; prevention relies on vector control and hygiene.
• Q: What’s the Jarisch–Herxheimer reaction?
  A: A transient worsening of symptoms (fever, hypotension) within hours after starting antibiotics.
• Q: Can it be fatal?
  A: Untreated, louse-borne relapsing fever can have a 5–10% mortality rate; tick-borne forms are less lethal with prompt care.
• Q: How do I prevent tick-borne relapsing fever?
  A: Use repellents, wear protective clothing, inspect for ticks, and rodent-proof cabins.
• Q: Are antibiotics the only option?
  A: Yes, there’s no proven herbal or alternative therapy—only antibiotics clear the bacteria.
• Q: How many relapses can I expect?
  A: Without treatment, patients may experience 3–10 febrile episodes; treatment reduces relapses to zero.
• Q: Does relapsing fever affect specific organs?
  A: It’s mainly blood-borne but can involve the CNS, liver, spleen, and sometimes the heart.
• Q: When should I seek emergency care?
  A: If you have confusion, severe headache, chest pain, or signs of low blood pressure.
• Q: Is telemedicine helpful?
  A: It’s great for initial guidance, result interpretation, and follow-ups, but you still need in-person exams and blood tests.